{"name":"CARsgen Therapeutics Co., Ltd.","slug":"carsgen-therapeutics-co-ltd","ticker":"","exchange":"","domain":"carsgen.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AB011 Injection","genericName":"AB011 Injection","slug":"ab011-injection","indication":"Other","status":"phase_1"},{"name":"CT011 CAR-GPC3 T Cells Injection","genericName":"CT011 CAR-GPC3 T Cells Injection","slug":"ct011-car-gpc3-t-cells-injection","indication":"Other","status":"phase_1"},{"name":"zevor-cel","genericName":"zevor-cel","slug":"zevor-cel","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AB011 Injection","genericName":"AB011 Injection","slug":"ab011-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CT011 CAR-GPC3 T Cells Injection","genericName":"CT011 CAR-GPC3 T Cells Injection","slug":"ct011-car-gpc3-t-cells-injection","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"zevor-cel","genericName":"zevor-cel","slug":"zevor-cel","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQRlBqRE9PSmxIVkQwVnB5a1dKMml3MUtpdDVxVlFJWmtKQkJMclpxZ04yUk40QXllWFJ4bS1hU04waVhZQTRSem1GTC10WTNwWlg2aWw2OURjUFZzck1wMWxFbWE1X0R6T002ODZnNU9tSElCclRBS2g4bGVubjZ3UGViWEphQy11M3VKT0NYX3k3UV80MzRQY2FiNllPbjlRcGJXZ0tlM3dxbTRfbmhvaHpacGd2c2FjUllpNGprNGZBRGdxTEZia1RkbG1ITFU5VTRwZnBHcmtxRlRwQS1uVE1pRzZOUQ?oc=5","date":"2026-03-27","type":"pipeline","source":"Barchart.com","summary":"Pancreatic Cancer Treatment Pipeline Shows Strong Momentum as 170+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Pancreatic Cancer Treatment Pipeline Shows Strong Momentum as 170+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQYWZBVGhIQXV1TUNPWkpMSnZFN1kwMXZmanNqYlF5RXd4eHlLV0N2M19KeXJ4ZGExUVBEQW9ScnRtZFBJeUM2MldjMGNzWEJPSEpiRGxUVlFmd05EQ3BXcHlFaTFkVjlSUkJKeWpFenh5UUJtY1J1NG42VnFpZjVyaGhaREI5QlYtMlN6U1NWd0dCSXNjeENkT2wwYjRjNG95OGZWRUhxazE?oc=5","date":"2026-02-13","type":"pipeline","source":"Contract Pharma","summary":"CARsgen to Expand Commercial Manufacturing Base in Shanghai - Contract Pharma","headline":"CARsgen to Expand Commercial Manufacturing Base in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOWkxfejZtN1NsRzd2Y3BCal9TQnc0aTN4Y3E0TDF4eVM4YmJMRHV3aTZ5WUtIMl9qWFJoUVlHQnFzMXUwZjY0cWxsWjlzR3lCcEc0NGFVVzJsT1hhM1hGblJFRWFNQUREUXA3dHdHeW5KS3dFN2tweEZBRDE3UHROMDdXTjJfc2ZMZHZyX3ZWY2dSYWdMclpRZ08zLXJpOHl6TENQdlFpM0JEYVZwQS1yZW1BUEJac1MzOHg3YWJQaGJyVGRSLUpfMEg1UHlLOHM?oc=5","date":"2025-12-28","type":"pipeline","source":"prnewswire.com","summary":"CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596 - prnewswire.com","headline":"CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxONUcyZkZtLVFSSWFpdGhncGlEYXF3OVZNV0lrMzB0M1dKNlhQUHFuLXZfT1V4NGdMSnV0UC1VektMVFA0SV8wQmd1LWxFTDZlZ2FlWlVHY3hYdjlEbEtIM3ctX2NqbHdkaTBpYnUwODdVTjNPR0xjeTFjTnZZejhVMHVnQ3JRcEoyS3lOSUtlcFBhRGc?oc=5","date":"2025-11-06","type":"pipeline","source":"Insightace Analytic","summary":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOTkNWVzJoN0lFa1V6cFJkdE5rMGVLY1hjVE1qUEtsU0ZLQUYzQmNKazBoWUNIX3NwUjJwS3QzRl9ET2tiZ042azZwRlpDMkJ0Ymw4dnF2akd4MmVzbzlka0ZtUW1IMWRXQUt5QTFrdUN4LVJsbkVBQU15LTllQmg5aW5ZSTV0b2g2TFEyR1VmWUE4cHFNX0JYLUlUWTdzeDFBd0RWRnFUclg1eXVRRnp3aVZPUmw1Z1pzNEZjN0Fzbi1oUWx4WUVZ?oc=5","date":"2025-10-07","type":"regulatory","source":"prnewswire.com","summary":"CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology - prnewswire.com","headline":"CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQSjViX3BYMzZrSk1PS01rcExLNDllZkZ0SGxXSGJXYkZsanVmYmYtcWdLV3E0azJ1Wm9oLWI1dE1SUHZpbXVoMUlERXpteXZzY2JhRE5RV19RYkhmc1BlYWNSaU1iSjI1QUlUOWVXSHFONHhsNnZuelJ3S1ZOSml2N0xFZThjN3FJcHRsNHNWM04wd3FvdE1hUGhnMXdNYnYwa3Q0bGlwYmQtN0lDdE5SODB1dk5xMHZDQzJWc1QyZkZmZkhhdmN1LW1vc0E?oc=5","date":"2025-02-28","type":"pipeline","source":"BioPharma APAC","summary":"CARsgen Doses First SLE Patient with KJ-C2219, a Dual-Target Allogeneic CAR-T Therapy - BioPharma APAC","headline":"CARsgen Doses First SLE Patient with KJ-C2219, a Dual-Target Allogeneic CAR-T Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQUnZ4Z3ZqVWJYanNJaDJ3SGFYRmxnMS1nbmJZWkluWlpNRGhTUFZGY0dTazJwNG50S2RTV3lteHloYWhzQm9WT3k3NF9BcDlnMDdyc2tiQnpaS3lTTk1nQ0hDREQxb002cmpVd3dEWGp1cVA1LTFFZDlvT3BKM09ycHZ0WGc5YXZBblRsMC1mdU1CWFhhdHNGZXJUUXVWWkhKX0V1NXhPYWs5S2c4WE9fYzZlTWQwMVZyUm10Wm02UkRyMkkxcEVRZFp6MThrSFhZMTRBUDh2emp4aGd6VjBUdDJHWE8wNGJTa2IwNEprSm14bDQ?oc=5","date":"2024-08-20","type":"trial","source":"BioPharma APAC","summary":"CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China - BioPharma APAC","headline":"CARsgen Therapeutics Completes Enrollment in Pivotal Phase II Trial of Satri-Cel for Advanced Gastric Cancer in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQVENZQWtTSVNqQ3FrQWRuR09aYWtKeVZ5T1UzZ21KbW9PaS14cTBRMjZGRm1YenV2WTMyazB4RTY4eXlBemFmb0tsZHBKSTlfcjk2RFZrdnZaZVRMQ3dQSDE5TDUwZnFsMktkT2RpX29MZnNwTERjMzBvMGJDc1RKc21PM1dRY2M1VXBpbTdGZWE0YXo4cmZJczlqTlFOTHRCM19IZzJyMWx2TnRaRnc?oc=5","date":"2023-01-17","type":"deal","source":"BioWorld News","summary":"Carsgen out-licenses China rights to Huadong for BCMA CAR T for $152M - BioWorld News","headline":"Carsgen out-licenses China rights to Huadong for BCMA CAR T for $152M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPREpDbE1sLXhtalcwRi1wUU0zSDJ4RHdoQ2VLT0VjRXNyTzRMUkd3NXJtQ0hxT1N0X184UWVmbm9rYmV4ZUpGRHBwQ21obmlIUUU3cEl6SW9TcWJWdW5MZXVRbC11NzVKNnFuWjlYNU5WM1MyWTR6bHNaZDFQM2w5UVNrNGdsbldGb2dyeXRlRGJCM3dsRkRZdFdmejhzMXBwRDdDbnFJNmxDWEtjM1NCR0U4bU9tWXJDRmtwX1Q2aWNJSFFxeXFySE5qR2dicmx0cldZaktNeE43WTZjaVdNN2steGkxcWFlclhodG5YeWlEQTZlVXphdXZHTWw0MWY3UVE2UEV6anNVdw?oc=5","date":"2023-01-16","type":"deal","source":"prnewswire.com","summary":"CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China - prnewswire.com","headline":"CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland Chi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxONEJmcEdJSVBJWWlIYkYzZ2VFN0xtYkZEczFCWnZodDlvY2dqXzI5SEFJVW9QM296NVNuekNiWUVlUlhpRDBpb2NSQ2FBZHNNcU9IQmItVEkzVHFuSEZXaW9OLW1wMVlscXFCU2ZBV2R4SHJJeG8tV0VUSi14alJYOE5rNnhLRHBMdnJIX1JPV2VTSXB4aURhOGRIN3RCRWM?oc=5","date":"2022-04-07","type":"pipeline","source":"citybiz","summary":"CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer - citybiz","headline":"CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}